Adults aged more than 70 who received more prescriptions for nirmatrelvir-ritonavir did not show decreased rates of ...
In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the ...
I could discuss risks and benefits in a more sophisticated way if I better understood a patient’s risk versus their ...
Health and Human Services Secretary Robert F. Kennedy Jr. paused a $240 million contract to create a new coronavirus vaccine.
Exploring alternative vaccine delivery systems could increase accessibility and encourage those who fear needles to receive ...
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results